Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2014

Open Access 01-12-2014 | Research

Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain

Authors: Itziar Gil-Pisa, Carolina Cebrián, Jorge E Ortega, J Javier Meana, David Sulzer

Published in: Journal of Neuroinflammation | Issue 1/2014

Login to get access

Abstract

Background

An accumulating body of evidence points to the significance of neuroinflammation and immunogenetics in schizophrenia, and an imbalance of cytokines in the central nervous system (CNS) has been suggested to be associated with the disorder. Munc18-overexpressing mice (Munc18-OE) have provided a model for the study of the alterations that may underlie the symptoms of subjects with schizophrenia. The aim of the present study was to elucidate the involvement of neuroinflammation and cytokine imbalance in this model.

Methods

Cytokines were evaluated in the cortex and the striatum of Munc18-OE and wild-type (WT) mice by enzyme-linked immunosorbent assay (ELISA). Protein levels of specific microglia and macrophage, astrocytic and neuroinflammation markers were quantified by western blot in the cortex and the striatum of Munc18-OE and WT mice.

Results

Each cytokine evaluated (Interferon-gamma (IFN-γ), Tumor Necrosis Factor-alpha (TNF-α), Interleukin-2 (IL-2) and CCL2 chemokine) was present at higher levels in the striatum of Munc18-OE mice than WT. Cortical TNF-α and IL-2 levels were significantly lower in Munc18-OE mice than WT mice. The microglia and macrophage marker CD11b was lower in the cortexes of Munc18-OE mice than WT, but no differences were observed in the striatum. Glial Fibrillary Acidic Protein (GFAP) and Nuclear Factor-kappaB (NF-κB)p65 levels were not different between the groups. Interleukin-1beta (IL-1β) and IL-6 levels were beneath detection limits.

Conclusions

The disrupted levels of cytokines detected in the brain of Munc18-OE mice was found to be similar to clinical reports and endorses study of this type for analysis of this aspect of the disorder. The lower CD11b expression in the cortex but not in the striatum of the Munc18-OE mice may reflect differences in physiological activity. The cytokine expression pattern observed in Munc18-OE mice is similar to a previously published model of schizophrenia caused by maternal immune activation. Together, these data suggest a possible role for an immune imbalance in this disorder.
Appendix
Available only for authorised users
Literature
2.
3.
go back to reference Weizman R, Laor N, Wiener Z, Wolmer L, Bessler H: Cytokine production in panic disorder patients. Clin Neuropharmacol. 1999, 22: 107-109.CrossRefPubMed Weizman R, Laor N, Wiener Z, Wolmer L, Bessler H: Cytokine production in panic disorder patients. Clin Neuropharmacol. 1999, 22: 107-109.CrossRefPubMed
4.
go back to reference Kronfol Z, Remick DG: Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000, 157: 683-694.CrossRefPubMed Kronfol Z, Remick DG: Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000, 157: 683-694.CrossRefPubMed
5.
go back to reference Banks WA, Moinuddin A, Morley JE: Regional transport of TNF-alpha across the blood–brain barrier in young ICR and young and aged SAMP8 mice. Neurobiol Aging. 2001, 22: 671-676.CrossRefPubMed Banks WA, Moinuddin A, Morley JE: Regional transport of TNF-alpha across the blood–brain barrier in young ICR and young and aged SAMP8 mice. Neurobiol Aging. 2001, 22: 671-676.CrossRefPubMed
6.
go back to reference Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T: Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990, 59: 783-836.CrossRefPubMed Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T: Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990, 59: 783-836.CrossRefPubMed
7.
go back to reference Freidin M, Bennett MV, Kessler JA: Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta. Proc Natl Acad Sci USA. 1992, 89: 10440-10443.PubMedCentralCrossRefPubMed Freidin M, Bennett MV, Kessler JA: Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta. Proc Natl Acad Sci USA. 1992, 89: 10440-10443.PubMedCentralCrossRefPubMed
8.
go back to reference Rothwell NJ, Luheshi G, Toulmond S: Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol Ther. 1996, 69: 85-95.CrossRefPubMed Rothwell NJ, Luheshi G, Toulmond S: Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol Ther. 1996, 69: 85-95.CrossRefPubMed
9.
go back to reference Haas HS, Schauenstein K: Neuroimmunomodulation via limbic structures–the neuroanatomy of psychoimmunology. Prog Neurobiol. 1997, 51: 195-222.CrossRefPubMed Haas HS, Schauenstein K: Neuroimmunomodulation via limbic structures–the neuroanatomy of psychoimmunology. Prog Neurobiol. 1997, 51: 195-222.CrossRefPubMed
10.
go back to reference Muller N, Ackenheil M: Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1998, 22: 1-33.CrossRefPubMed Muller N, Ackenheil M: Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1998, 22: 1-33.CrossRefPubMed
11.
go back to reference Mehler MF, Kessler JA: Cytokines in brain development and function. Adv Protein Chem. 1998, 52: 223-251.CrossRefPubMed Mehler MF, Kessler JA: Cytokines in brain development and function. Adv Protein Chem. 1998, 52: 223-251.CrossRefPubMed
12.
go back to reference American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders-IV-TR. 2000, New York: American Psychiatric Association American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders-IV-TR. 2000, New York: American Psychiatric Association
13.
go back to reference Sperner-Unterweger B: Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs. 2005, 65: 1493-1520.CrossRefPubMed Sperner-Unterweger B: Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs. 2005, 65: 1493-1520.CrossRefPubMed
14.
go back to reference Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS: Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun. 2006, 20: 532-545.CrossRefPubMed Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS: Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun. 2006, 20: 532-545.CrossRefPubMed
15.
16.
go back to reference Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B: Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011, 70: 663-671.PubMedCentralCrossRefPubMed Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B: Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011, 70: 663-671.PubMedCentralCrossRefPubMed
17.
go back to reference Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008, 63: 801-808.CrossRefPubMed Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008, 63: 801-808.CrossRefPubMed
18.
go back to reference Johnson RD, Oliver PL, Davies KE: SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. Acta Biochim Pol. 2008, 55: 619-628.PubMed Johnson RD, Oliver PL, Davies KE: SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. Acta Biochim Pol. 2008, 55: 619-628.PubMed
19.
go back to reference Voets T, Toonen RF, Brian EC, de Wit H, Moser T, Rettig J, Südhof TC, Neher E, Verhage M: Munc18-1 promotes large dense-core vesicle docking. Neuron. 2001, 31: 581-591.CrossRefPubMed Voets T, Toonen RF, Brian EC, de Wit H, Moser T, Rettig J, Südhof TC, Neher E, Verhage M: Munc18-1 promotes large dense-core vesicle docking. Neuron. 2001, 31: 581-591.CrossRefPubMed
20.
go back to reference Castillo MA, Ghose S, Tamminga CA, Ulery-Reynolds PG: Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex. Biol Psychiatry. 2010, 67: 208-216.CrossRefPubMed Castillo MA, Ghose S, Tamminga CA, Ulery-Reynolds PG: Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex. Biol Psychiatry. 2010, 67: 208-216.CrossRefPubMed
21.
go back to reference Toonen RF, Verhage M: Munc18-1 in secretion: lonely Munc joins SNARE team and takes control. Trends Neurosci. 2007, 30: 564-572.CrossRefPubMed Toonen RF, Verhage M: Munc18-1 in secretion: lonely Munc joins SNARE team and takes control. Trends Neurosci. 2007, 30: 564-572.CrossRefPubMed
22.
go back to reference Burgoyne RD, Barclay JW, Ciufo LF, Graham ME, Handley MT, Morgan A: The functions of Munc18-1 in regulated exocytosis. Ann N Y Acad Sci. 2009, 1152: 76-86.CrossRefPubMed Burgoyne RD, Barclay JW, Ciufo LF, Graham ME, Handley MT, Morgan A: The functions of Munc18-1 in regulated exocytosis. Ann N Y Acad Sci. 2009, 1152: 76-86.CrossRefPubMed
23.
go back to reference Behan AT, Byrne C, Dunn MJ, Cagney G, Cotter DR: Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol Psychiatry. 2009, 14: 601-613.CrossRefPubMed Behan AT, Byrne C, Dunn MJ, Cagney G, Cotter DR: Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol Psychiatry. 2009, 14: 601-613.CrossRefPubMed
24.
go back to reference Gil-Pisa I, Munarriz-Cuezva E, Ramos-Miguel A, Uriguen L, Meana JJ, Garcia-Sevilla JA: Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment. Int J Neuropsychopharmacol. 2012, 15: 573-588.CrossRefPubMed Gil-Pisa I, Munarriz-Cuezva E, Ramos-Miguel A, Uriguen L, Meana JJ, Garcia-Sevilla JA: Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment. Int J Neuropsychopharmacol. 2012, 15: 573-588.CrossRefPubMed
25.
go back to reference Garcia EP, McPherson PS, Chilcote TJ, Takei K, De Camilli P: rbSec1A and B colocalize with syntaxin 1 and SNAP-25 throughout the axon, but are not in a stable complex with syntaxin. J Cell Biol. 1995, 129: 105-120.CrossRefPubMed Garcia EP, McPherson PS, Chilcote TJ, Takei K, De Camilli P: rbSec1A and B colocalize with syntaxin 1 and SNAP-25 throughout the axon, but are not in a stable complex with syntaxin. J Cell Biol. 1995, 129: 105-120.CrossRefPubMed
26.
go back to reference Swanson DA, Steel JM, Valle D: Identification and characterization of the human ortholog of rat STXBP1, a protein implicated in vesicle trafficking and neurotransmitter release. Genomics. 1998, 48: 373-376.CrossRefPubMed Swanson DA, Steel JM, Valle D: Identification and characterization of the human ortholog of rat STXBP1, a protein implicated in vesicle trafficking and neurotransmitter release. Genomics. 1998, 48: 373-376.CrossRefPubMed
27.
go back to reference Uriguen L, Gil-Pisa I, Munarriz-Cuezva E, Berrocoso E, Pascau J, Soto-Montenegro ML, Gutierrez-Adan A, Pintado B, Madrigal JL, Castro E, Sánchez-Blázquez P, Ortega JE, Guerrero MJ, Ferrer-Alcón M, García-Sevilla JA, Micó JA, Desco M, Leza JC, Pazos Á, Garzón J, Meana JJ: Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia. Transl Psychiatry. 2013, 3: e221.PubMedCentralCrossRefPubMed Uriguen L, Gil-Pisa I, Munarriz-Cuezva E, Berrocoso E, Pascau J, Soto-Montenegro ML, Gutierrez-Adan A, Pintado B, Madrigal JL, Castro E, Sánchez-Blázquez P, Ortega JE, Guerrero MJ, Ferrer-Alcón M, García-Sevilla JA, Micó JA, Desco M, Leza JC, Pazos Á, Garzón J, Meana JJ: Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia. Transl Psychiatry. 2013, 3: e221.PubMedCentralCrossRefPubMed
28.
go back to reference Braff DL, Geyer MA, Swerdlow NR: Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001, 156: 234-258.CrossRef Braff DL, Geyer MA, Swerdlow NR: Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001, 156: 234-258.CrossRef
29.
go back to reference O’Tuathaigh CM, Kirby BP, Moran PM, Waddington JL: Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia. Schizophr Bull. 2010, 36: 271-288.PubMedCentralCrossRefPubMed O’Tuathaigh CM, Kirby BP, Moran PM, Waddington JL: Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia. Schizophr Bull. 2010, 36: 271-288.PubMedCentralCrossRefPubMed
31.
go back to reference Khasnavis S, Jana A, Roy A, Mazumder M, Bhushan B, Wood T, Ghosh S, Watson R, Pahan K: Suppression of nuclear factor-kappaB activation and inflammation in microglia by physically modified saline. J Biol Chem. 2012, 287: 29529-29542.PubMedCentralCrossRefPubMed Khasnavis S, Jana A, Roy A, Mazumder M, Bhushan B, Wood T, Ghosh S, Watson R, Pahan K: Suppression of nuclear factor-kappaB activation and inflammation in microglia by physically modified saline. J Biol Chem. 2012, 287: 29529-29542.PubMedCentralCrossRefPubMed
32.
go back to reference Luber-Narod J, Rogers J: Immune system associated antigens expressed by cells of the human central nervous system. Neurosc Lett. 1988, 94: 17-22.CrossRef Luber-Narod J, Rogers J: Immune system associated antigens expressed by cells of the human central nervous system. Neurosc Lett. 1988, 94: 17-22.CrossRef
33.
go back to reference García-Bueno B, Bioque M, Mac-Dowell KS, Barcones MF, Martínez-Cengotitabengoa M, Pina-Camacho L, Rodríguez-Jiménez R, Sáiz PA, Castro C, Lafuente A, Santabárbara J, González-Pinto A, Parellada M, Rubio G, García-Portilla MP, Micó JA, Bernardo M, Leza JC: Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis if schizophrenia. Schizophr Bull. 2014, 40: 376-387.PubMedCentralCrossRefPubMed García-Bueno B, Bioque M, Mac-Dowell KS, Barcones MF, Martínez-Cengotitabengoa M, Pina-Camacho L, Rodríguez-Jiménez R, Sáiz PA, Castro C, Lafuente A, Santabárbara J, González-Pinto A, Parellada M, Rubio G, García-Portilla MP, Micó JA, Bernardo M, Leza JC: Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis if schizophrenia. Schizophr Bull. 2014, 40: 376-387.PubMedCentralCrossRefPubMed
34.
go back to reference Roussos P, Katsel P, Davis KL, Giakoumaki SG, Siever LJ, Bitsios P, Haroutunian V: Convergent findings for abnormalities of the NF-kappaB signaling pathways in schizophrenia. Neuropsychopharmacol. 2013, 38: 533-539.CrossRef Roussos P, Katsel P, Davis KL, Giakoumaki SG, Siever LJ, Bitsios P, Haroutunian V: Convergent findings for abnormalities of the NF-kappaB signaling pathways in schizophrenia. Neuropsychopharmacol. 2013, 38: 533-539.CrossRef
35.
go back to reference Davis KL, Kahn RS, Ko G, Davidson M: Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991, 148: 1474-1486.CrossRefPubMed Davis KL, Kahn RS, Ko G, Davidson M: Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991, 148: 1474-1486.CrossRefPubMed
36.
go back to reference Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987, 44: 660-669.CrossRefPubMed Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987, 44: 660-669.CrossRefPubMed
37.
go back to reference Davidson LL, Heinrichs RW: Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Res. 2003, 122: 69-87.CrossRefPubMed Davidson LL, Heinrichs RW: Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Res. 2003, 122: 69-87.CrossRefPubMed
38.
go back to reference Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, Bearden CE, Velligan DI: Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp. 2005, 25: 60-69.CrossRefPubMed Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, Bearden CE, Velligan DI: Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp. 2005, 25: 60-69.CrossRefPubMed
39.
go back to reference Hill K, Mann L, Laws KR, Stephenson CM, Nimmo-Smith I, McKenna PJ: Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr Scand. 2004, 110: 243-256.CrossRefPubMed Hill K, Mann L, Laws KR, Stephenson CM, Nimmo-Smith I, McKenna PJ: Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr Scand. 2004, 110: 243-256.CrossRefPubMed
40.
go back to reference Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG: Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med. 1997, 38: 389-398.CrossRefPubMed Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG: Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med. 1997, 38: 389-398.CrossRefPubMed
41.
go back to reference Pycock CJ, Kerwin RW, Carter CJ: Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 1980, 286: 74-76.CrossRefPubMed Pycock CJ, Kerwin RW, Carter CJ: Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 1980, 286: 74-76.CrossRefPubMed
42.
go back to reference Grace AA: Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 1991, 41: 1-24.CrossRefPubMed Grace AA: Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 1991, 41: 1-24.CrossRefPubMed
43.
go back to reference Deutch AY: The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm Suppl. 1992, 36: 61-89.PubMed Deutch AY: The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm Suppl. 1992, 36: 61-89.PubMed
44.
go back to reference Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF: Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci. 2002, 5: 267-271.CrossRefPubMed Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF: Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci. 2002, 5: 267-271.CrossRefPubMed
45.
go back to reference Ingvar DH, Franzen G: Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand. 1974, 50: 425-462.CrossRefPubMed Ingvar DH, Franzen G: Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand. 1974, 50: 425-462.CrossRefPubMed
46.
go back to reference Buchsbaum MS: The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull. 1990, 16: 379-389.CrossRefPubMed Buchsbaum MS: The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull. 1990, 16: 379-389.CrossRefPubMed
47.
go back to reference Bullmore E, Brammer M, Williams SC, Curtis V, McGuire P, Morris R, Murray R, Sharma T: Functional MR imaging of confounded hypofrontality. Hum Brain Mapp. 1999, 8: 86-91.CrossRefPubMed Bullmore E, Brammer M, Williams SC, Curtis V, McGuire P, Morris R, Murray R, Sharma T: Functional MR imaging of confounded hypofrontality. Hum Brain Mapp. 1999, 8: 86-91.CrossRefPubMed
48.
go back to reference Shi L, Fatemi SH, Sidwell RW, Patterson PH: Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci. 2003, 23: 297-302.PubMed Shi L, Fatemi SH, Sidwell RW, Patterson PH: Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci. 2003, 23: 297-302.PubMed
49.
go back to reference Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M: Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry. 2006, 59: 546-554.CrossRefPubMed Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M: Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry. 2006, 59: 546-554.CrossRefPubMed
50.
go back to reference Meyer U, Engler A, Weber L, Schedlowski M, Feldon J: Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience. 2008, 154: 701-709.CrossRefPubMed Meyer U, Engler A, Weber L, Schedlowski M, Feldon J: Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience. 2008, 154: 701-709.CrossRefPubMed
51.
go back to reference Banks WA: Blood–brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des. 2005, 11: 973-984.CrossRefPubMed Banks WA: Blood–brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des. 2005, 11: 973-984.CrossRefPubMed
52.
go back to reference Pollmacher T, Haack M, Schuld A, Reichenberg A, Yirmiya R: Low levels of circulating inflammatory cytokines–do they affect human brain functions?. Brain Behav Immun. 2002, 16: 525-532.CrossRefPubMed Pollmacher T, Haack M, Schuld A, Reichenberg A, Yirmiya R: Low levels of circulating inflammatory cytokines–do they affect human brain functions?. Brain Behav Immun. 2002, 16: 525-532.CrossRefPubMed
53.
go back to reference Stanley AC, Lacy P: Pathways fro cytokine secretion. Physiol. 2010, 25: 218-229.CrossRef Stanley AC, Lacy P: Pathways fro cytokine secretion. Physiol. 2010, 25: 218-229.CrossRef
54.
go back to reference Lee M: Neurotransmitter and microglial-mediated neuroinflammation. Curr Protein Pept Sci. 2013, 14: 21-32.CrossRefPubMed Lee M: Neurotransmitter and microglial-mediated neuroinflammation. Curr Protein Pept Sci. 2013, 14: 21-32.CrossRefPubMed
55.
go back to reference Fineberg AM, Ellman LM: Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry. 2013, 73: 951-966.PubMedCentralCrossRefPubMed Fineberg AM, Ellman LM: Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry. 2013, 73: 951-966.PubMedCentralCrossRefPubMed
Metadata
Title
Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain
Authors
Itziar Gil-Pisa
Carolina Cebrián
Jorge E Ortega
J Javier Meana
David Sulzer
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2014
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-11-128

Other articles of this Issue 1/2014

Journal of Neuroinflammation 1/2014 Go to the issue